FI965196A - HIV-infektion yhdistelmähoito - Google Patents

HIV-infektion yhdistelmähoito Download PDF

Info

Publication number
FI965196A
FI965196A FI965196A FI965196A FI965196A FI 965196 A FI965196 A FI 965196A FI 965196 A FI965196 A FI 965196A FI 965196 A FI965196 A FI 965196A FI 965196 A FI965196 A FI 965196A
Authority
FI
Finland
Prior art keywords
combination therapy
hiv infection
hiv
infection
therapy
Prior art date
Application number
FI965196A
Other languages
English (en)
Swedish (sv)
Other versions
FI965196A0 (fi
Inventor
Emilio A Emini
Joel R Huff
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI965196A0 publication Critical patent/FI965196A0/fi
Publication of FI965196A publication Critical patent/FI965196A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
FI965196A 1994-06-27 1996-12-23 HIV-infektion yhdistelmähoito FI965196A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26708594A 1994-06-27 1994-06-27
PCT/US1995/007690 WO1996000068A2 (en) 1994-06-27 1995-06-23 Combination therapy for hiv infection

Publications (2)

Publication Number Publication Date
FI965196A0 FI965196A0 (fi) 1996-12-23
FI965196A true FI965196A (fi) 1996-12-23

Family

ID=23017251

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965196A FI965196A (fi) 1994-06-27 1996-12-23 HIV-infektion yhdistelmähoito

Country Status (14)

Country Link
EP (1) EP0767664A2 (fi)
JP (1) JPH10503178A (fi)
AU (1) AU2863895A (fi)
CA (1) CA2193221A1 (fi)
CZ (1) CZ375196A3 (fi)
FI (1) FI965196A (fi)
HU (1) HUT76546A (fi)
IL (1) IL114208A0 (fi)
MX (1) MX9700036A (fi)
NO (1) NO965591L (fi)
PL (1) PL317876A1 (fi)
SK (1) SK163996A3 (fi)
WO (1) WO1996000068A2 (fi)
ZA (1) ZA955269B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689761B1 (en) * 1995-02-01 2004-02-10 Merck & Co., Inc. Combination therapy for HIV infection
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
EP0872233A1 (en) * 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
GB2324242A (en) * 1997-04-18 1998-10-21 Atindra Nath Chakrabarty Medicaments for treating viral infections
EA005423B1 (ru) 1999-09-24 2005-02-24 Янссен Фармацевтика Н.В. Противовирусные композиции
EP3353527B1 (en) 2015-09-23 2022-12-28 Malvern Panalytical Limited Particle characterisation

Also Published As

Publication number Publication date
WO1996000068A2 (en) 1996-01-04
FI965196A0 (fi) 1996-12-23
SK163996A3 (en) 1997-08-06
HUT76546A (en) 1997-09-29
NO965591D0 (no) 1996-12-27
PL317876A1 (en) 1997-04-28
AU2863895A (en) 1996-01-19
NO965591L (no) 1996-12-27
JPH10503178A (ja) 1998-03-24
MX9700036A (es) 1997-04-30
IL114208A0 (en) 1995-10-31
HU9603567D0 (en) 1997-02-28
ZA955269B (en) 1996-02-02
CZ375196A3 (en) 1997-07-16
EP0767664A2 (en) 1997-04-16
WO1996000068A3 (en) 1996-02-22
CA2193221A1 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
NO964106D0 (no) Spröyte
DE69416887T2 (de) Wegwerfhöschen
FI953751A0 (fi) Pyörätuoli
DE69532869D1 (de) Sicherheitsspritze
DK0769017T3 (da) Terapeutiske forbindelser
BR9503004A (pt) Conjunto de seringa
ZA96722B (en) Combination therapy for hiv infection
DE69524487D1 (de) Sterilisiervorrichtung
FI965196A (fi) HIV-infektion yhdistelmähoito
FI953752A (fi) Pyörätuoli
DE59510194D1 (de) Dose
ZA956662B (en) Combination therapy for HIV infection
KR950022733U (ko) 세척기
KR960013409U (ko) 안전 주사기
DE9402893U1 (de) Therapeutischer Strumpf
DE9408862U1 (de) Rollstuhl
KR950026319U (ko) 치료환자용 팬티
DE9419735U1 (de) Medizinischer Schutzverband
FI941405A0 (fi) Potilasnostin
DE9401145U1 (de) Medizinisches Handstück
ES1029117Y (es) Mascarilla terapeutica desechable.
KR950022766U (ko) 일회용 구급 약솜
KR950026744U (ko) 주사기
KR960016384U (ko) 주사기
SE9202787D0 (sv) Patientanslutning

Legal Events

Date Code Title Description
FD Application lapsed